Journal:JAMA Oncology

Co-author:Peng Liubao, Zeng Xiaohui, Tan Chongqing, Zhang Yucong, Wan Xiaomin

Indexed by:Applied Research

Document Type:J

Volume:5

Issue:4

Page Number:491-496

Translation or Not:no

Pre One:First-Line Atezolizumab in Addition to Bevacizumab Plus Chemotherapy for Metastatic, Nonsquamous Non–Small Cell Lung Cancer: A United States–Based Cost-Effectiveness Analysis